Trial Profile
Expanded Access Use of Stiripentol in Participants With Dravet Syndrome or Epileptic Encephalopathies Associated With Sodium Channel Mutations
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Stiripentol (Primary)
- Indications Dravet syndrome; Encephalopathy; Epilepsy
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 16 Sep 2014 New trial record